skip to content

ESG in Life Sciences

ESG programs for Life Sciences

In today’s world, environmental, social, and governance (ESG) is a core pillar of value creation for organizations of all sizes. In order to meet stakeholders’ evolving expectations and pending regulatory requirements, the life sciences sector needs to incorporate ESG into its business operations.

ESG issues specific to Life Sciences

Every industry has different driving forces behind the development of ESG programs. The following issues are material to the agriculture sector:

The life sciences sector needs to make medicines more sustainable, reduce greenhouse gas (GHG) emissions in the process, and support innovation.

With increased literature speaking to the importance of diversity in clinical trials, life sciences organizations need to enhance their measures for further inclusion and diversity.

Upcoming regulation on public companies to disclose and report on their scope 1, 2, and 3 GHG will put pressure on the entire supply chain and life science companies to map out their carbon footprint.

Life science companies are held to a higher standard when it comes to motive, regulation, and profit. The sector needs to ensure that a strong governance structure is in place to maintain regulatory compliance.

Benefits of investing in ESG programs for Life Sciences:

Early integration of an ESG program strategically positions your organization for long-term success
Supply chain optimization considering ESG imperatives.
Access to capital
Operational efficiency and innovation
Talent attraction and retention
Regulatory compliance
Partnership opportunities and community impact
Improved quality of life through research and products

This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our privacy statement for more information on the cookies we use and how to delete or block them.

Accept and close